Research suggests that immunity induced by sars-cov-2 infection may reduce rates of reinfection and hospitalization caused by the delta or omicron variants. Studies indicate that prior immunity, whether from infection or vaccination, may lead to milder covid-19 symptoms. The extent of protection offered by natural and hybrid immunity is being examined in various studies, with some research focusing on hospitalization rates and symptom severity.